Yan-Dong Tang,Changqing Yu,Xue-Hui Cai

Trends Microbiol.2023 Oct 3:S0966-842X(23)00263-9.doi: 10.1016/j.tim.2023.09.002. Online ahead of print.

Review

Abstract

Conditionally replicating viruses (CRVs) are a type of virus with one or more essential gene functions that are impaired resulting in the disruption of viral genome replication, protein synthesis, or virus particle assembly. CRVs can replicate only if the deficient essential genes are supplied. CRVs are widely used in biomedical research, particularly as vaccines. Traditionally, CRVs are generated by creating complementary cell lines that provide the impaired genes. With the development of biotechnology, novel techniques have been invented to generate CRVs, such as targeted protein degradation (TPD) technologies and premature termination codon (PTC) read-through technologies. The advantages and disadvantages of these novel technologies are discussed. Finally, we provide perspectives on what challenges need to be overcome for CRVs to reach the market.

Keywords: PROTAC virus; PTC virus; anticodon engineered tRNA; conditionally replicating virus; genetic codon expansion; vaccine.